Lv1
100 积分 2021-06-17 加入
Lurbinectedin: A New Treatment Option for Relapsed/Refractory Small-Cell Lung Cancer
2个月前
已完结
Polatuzumab vedotin extravasation injury: a case report
4个月前
已完结
Preliminary Safety and Efficacy of Zanubrutinib in Combination with Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
5个月前
已关闭
How I Treat Older Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
5个月前
已完结
皖公网安备34019202002308
